Summary:
A Randomized, Double-blind, Placebo-controlled, Multicenter, Efficacy and Safety
Study of Rapastinel for Rapid Treatment of Symptoms of Depression and
Suicidality in Adult Patients with Major Depressive Disorder
Qualified Participants Must:
Male or female outpatients, 18 to 65 years of age
Qualified Participants May Receive:
Compensation for time and gas